Extracellular Nef Protein Targets CD4+ T Cells for Apoptosis by Interacting with CXCR4 Surface Receptors

Journal of Virology

Volumn 78, Issue 6, 2004, Pages 3099-3109

  James, Cleve O ^a   Huang, Ming Bo ^a   Khan, Mafuz ^a   Garcia Barrio, Minerva ^a   Powell, Michael D ^a   Bond, Vincent C ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CASPASE; CASPASE 3; CD4 ANTIGEN; CELL RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTIBODY; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTIBODY; NEF PROTEIN; PROTEIN KINASE INHIBITOR; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; EXPRESSION VECTOR; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; GENE PRODUCTS, NEF; HIV-1; HUMANS; JURKAT CELLS; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 1542317632     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.6.3099-3109.2004     Document Type: Article

References (68)

1. Akari, H., Y. Yamamoto, H. Hiwada, Y. Saito, N. Takayanagi, A. H. Koyama, and A. Adachi. 1998. Suppression of HIV-1 replication in peripheral blood mononuclear cells by fasudil. J. Med. Investig. 44:211-214.
2. Albini, A., S. Ferrini, R. Benelli, S. Sforzini, D. Giunciuglio, M. G. Aluigi, A. E. Proudfoot, S. Alouani, T. N. Wells, G. Mariani, R. L. Rabin, J. M. Farber, and D. M. Noonan. 1998. HIV-1 Tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA 95:13153-13158.
3. Anderson, R. W., M. S. Ascher, and H. W. Sheppard. 1998. Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17:245-252.
4. Arold, S., F. Hoh, S. Domergue, C. Birck, M. A. Delsuc, M. Jullien, and C. Dumas. 2000. Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein. Protein Sci. 9:1137-1148.
5. Azad, A. A. 2000. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells? Biochem. Biophys. Res. Commun. 267:677-685.
6. Bagetta, G., M. T. Corasaniti, L. Berliocchi, M. Navarra, A. Finazzi-Agro, and G. Nistico. 1995. HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. Biochem. Biophys. Res. Commun. 211:130-136.
7. Bagetta, G., M. T. Corasaniti, L. Berliocchi, R. Nistico, A. M. Giammarioli, W. Malorni, L. Aloe, and A. Finazzi-Agro. 1999. Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience 89:1051-1066.
8. Biard-Piechaczyk, M., V. Robert-Hebmann, V. Richard, J. Roland, R. A. Hipskind, and C. Devaux. 2000. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Virology 268:329-344.
9. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
10. Cohen, G. M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326:1-16.
11. Collins, K. L., B. K. Chen, S. A. Kalams, B. D. Walker, and D. Baltimore. 1998. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391:397-401.
12. Corasaniti, M. T., M. C. Strongoli, S. Piccirilli, R. Nistico, A. Costa, A. Bilotta, P. Turano, A. Finazzi-Agro, and G. Bagetta. 2000. Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G. Biochem. Biophys. Res. Commun. 274:664-669.
13. Dalgleish, A. G., P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763-767.
14. Dickie, P. 1996. HIV type 1 Nef perturbs eye lens development in transgenic mice. AIDS Res. Hum. Retrovir. 12:177-189.
15. Dickie, P. 2000. Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice. AIDS Res. Hum. Retrovir. 16:777-790.
16. Dickie, P., J. Felser, M. Eckhaus, J. Bryant, J. Silver, N. Marinos, and A. L. Notkins. 1991. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185:109-119.
17. Dickie, P., F. Ramsdell, A. L. Notkins, and S. Venkatesan. 1993. Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 197:431-438.
18. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:129-134.
19. Fujii, Y., K. Otake, M. Tashiro, and A. Adachi. 1996. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett. 393:93-96.
20. Geleziunas, R., W. Xu, K. Takeda, H. Ichijo, and W. C. Greene. 2001. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410:834-838.
21. Goudreau, G., S. Carpenter, N. Beaulieu, and P. Jolicoeur. 1996. Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter. Nat. Med. 2:655-661.
22. Gould, S. J., A. M. Booth, and J. E. Hildreth. 2003. The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. USA 100:10592-10597.
23. Greenway, A. L., D. A. McPhee, K. Allen, R. Johnstone, G. Holloway, J. Mills, A. Azad, S. Sankovich, and P. Lambert. 2002. Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J. Virol. 76:2692-2702.
24. Hanna, Z., D. G. Kay, M. Cool, S. Jothy, N. Rebai, and P. Jolicoeur. 1998. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol. 72:121-132.
25. Hanna, Z., D. G. Kay, N. Rebai, A. Guimond, S. Jothy, and P. Jolicoeur. 1998. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95:163-175.
26. Hesselgesser, J., D. Taub, P. Baskar, M. Greenberg, J. Hoxie, D. L. Kolson, and R. Horuk. 1998. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8:595-598.
27. Hoxie, J. A., J. D. Alpers, J. L. Rackowski, K. Huebner, B. S. Haggarty, A. J. Cedarbaum, and J. C. Reed. 1986. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234:1123-1127.
28. Huang, M. B., and V. C. Bond. 2000. Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium. J. Acquir. Immune Defic. Syndr. 25:375-389.
29. Huang, M. B., M. Hunter, and V. C. Bond. 1999. Effect of extracellular human immunodeficiency virus type 1 glycoprotein 120 on primary human vascular endothelial cell cultures. AIDS Res. Hum. Retrovir. 15:1265-1277.
30. Huang, M. B., M. Khan, M. Garcia-Barrio, M. Powell, and V. C. Bond. 2001. Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120. J. Acquir. Immune Defic. Syndr. 27:213-221.
31. Ikuta, K., M. Kameoka, and R. B. Luftig. 1997. AIDS pathogenesis: the role of accessory gene mutations, leading to formation of long-lived persistently infected cells and/or apoptosis-inducing HIV-1 particles. Virus Res. 52:145-156.
32. Jekle, A., O. T. Keppler, E. De Clercq, D. Schols, M. Weinstein, and M. A. Goldsmith. 2003. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J. Virol. 77:5846-5854.
33. Jolicoeur, P., D. G. Kay, M. Cool, S. Jotby, N. Rebai, and Z. Hanna. 1999. A novel mouse model of HIV-1 disease. Leukemia 13(Suppl. 1):S78-S80.
34. Kaul, M., and S. A. Lipton. 1999. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96: 8212-8216.
35. Klatzmann, D., F. Barre-Sinoussi, M. T. Nugeyre, C. Dauguet, E. Vilmer, C. Griscelli, F. Brun-vezinet, C. Rouzioux, J. C. Gluckman, and J. C. Chermann. 1984. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225:59-63.
36. Klatzmann, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767-768.
37. Klimiuk, P. A., K. Bernacka, and A. Kuryllszyn-Moskal. 1995. Apoptosis in autoimmune diseases. Rocz. Akad. Med. Bialymst. 40:227-232.
38. Kuiken, C. L., B. Foley, B. Habn, P. A. Marx, F. McCutchan, J. W. Mellors, S. Wolinksy, and B. Korber (ed.). 2001. HIV sequence compendium 2001. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
39. Lambotte, O., A. Demoustier, M. G. de Goer, C. Wallon, J. Gasnault, C. Goujard, J. F. Delfraissy, and Y. Taoufik. 2002. Persistence of replication-competent HIV in both memory and naive CD4 T cell subsets in patients on prolonged and effective HAART. AIDS 16:2151-2157.
40. Lannuzel, A., J. V. Barnier, C. Hery, V. T. Huynh, B. Guibert, F. Gray, J. D. Vincent, and M. Tardieu. 1997. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann. Neurol. 42:847-856.
41. Macreadie, I. G., L. A. Castelli, A. Lucantoni, and A. A. Azad. 1995. Stress- and sequence-dependent release into the culture medium of HIV-1 Nef produced in Saccharomyces cerevisiae. Gene 162:239-243.
42. Meucci, O., A. Fatatis, A. A. Simen, T. J. Bushell, P. W. Gray, and R. J. Miller. 1998. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. USA 95:14500-14505.
43. Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Bucbanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A. Mohar, E. Verastegui, and A. Zlotnik. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
44. Nanki, T., and P. E. Lipsky. 2000. Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J. Immunol. 164:5010-5014.
45. Nickel, W. 2003. The mystery of nonclassical protein secretion: a current view on cargo proteins and potential export routes. Eur. J. Biochem. 270: 2109-2119.
46. Okada, H., S. Morikawa, and M. Tashiro. 1998. HIV-1 Nef binding protein expressed on the surface of murine blood cells. Med. Microbiol. Immunol. (Berlin) 186:201-207.
47. Okada, H., R. Takei, and M. Tashiro. 1997. HIV-1 Nef protein-induced apoptotic cytolysis of a broad spectrum of uninfected human blood cells independently of CD95(Fas). FEBS Lett. 414:603-606.
48. Okada, H., R. Takei, and M. Tashiro. 1997. Nef protein of HIV-1 induces apoptotic cytolysis of murine lymphoid cells independently of CD95 (Fas) and its suppression by serine/threonine protein kinase inhibitors. FEBS Lett. 417:61-64.
49. Okada, H., R. Takei, and M. Tashiro. 1998. Inhibition of HIV-1 Nef-induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3. FEBS Lett. 422:363-367.
50. Quick, J., J. A. Ware, and P. E. Driedger. 1992. The structure and biological activities of the widely used protein kinase inhibitor, H7, differ depending on the commercial source. Biochem. Biophys. Res. Commun. 187:657-663.
51. Raff, M. 1998. Cell suicide for beginners. Nature 396:119-122.
52. Reid, W., M. Sadowska, F. Denaro, S. Rao, J. Foulke, Jr., N. Hayes, O. Jones, D. Doodnauth, H. Davis, A. Sill, P. O'Driscoll, D. Huso, T. Fouts, G. Lewis, M. Hill, R. Kamin-Lewis, C. Wei, P. Ray, R. C. Gallo, M. Reitz, and J. Bryant. 2001. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl. Acad. Sci. USA 98:9271-9276.
53. Silvestris, F., D. Ribatti, B. Nico, N. Silvestris, A. Romito, and F. Dammacco. 1995. Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms. Ann. Ital. Med. Int. 10:7-13. (In Italian.)
54. Simard, M. C., P. Chrobak, D. G. Kay, Z. Hanna, S. Jothy, and P. Jolicoeur. 2002. Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease. J. Virol. 76:3981-3995.
55. Slee, E. A., C. Adrain, and S. J. Martin. 1999. Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 6:1067-1074.
56. Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, D. R. Green, and S. J. Martin. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:281-292.
57. Spies, C. P., and R. W. Compans. 1993. Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins. J. Virol. 67:6535-6541.
58. Studzinski, G. P. (ed.). 1999. Apoptosis: a practical approach, p. 1-16. Oxford University Press, Oxford, United Kingdom.
59. Thomas, F. P., C. Chalk, R. Lalonde, Y. Robitaille, and P. Jolicoeur. 1994. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J. Virol. 68:7099-7107.
60. Thornberry, N. A., and Y. Lazebnik. 1998. Caspases: enemies within. Science 281:1312-1316.
61. Tuosto, L., M. S. Montani, S. Lorenzetti, E. Cundari, S. Moretti, G. Lombardi, and E. Piccolella. 1995. Differential susceptibility to monomeric HIV gp120-mediated apoptosis in antigen-activated CD4+ T cell populations. Eur. J. Immunol. 25:2907-2916.
62. Ullrich, C. K., J. E. Groopman, and R. K. Ganju. 2000. HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood 96:1438-1442.
63. Vene, R., R. Benelli, D. M. Noonan, and A. Albini. 2000. HIV-Tat dependent chemotaxis and invasion, key aspects of tat mediated pathogenesis. Clin. Exp. Metastasis 18:533-538.
64. Wain-Hobson, S. 1997. Down or out in blood and lymph? Nature 387:123-124.
65. Xu, X. N., B. Laffert, G. R. Screaton, M. Kraft, D. Wolf, W. Kolanus, J. Mongkolsapay, A. J. McMichael, and A. S. Baur. 1999. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 189:1489-1496.
66. Yoon, K., J. G. Jeong, and S. Kim. 2001. Stable expression of human immunodeficiency virus type 1 Nef confers resistance against Fas-mediated apoptosis. AIDS Res. Hum. Retrovir. 17:99-104.
67. Zhang, J., and C. S. Crumpacker. 2001. Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy. J. Infect. Dis. 184:1341-1344.
68. Zheng, J., A. Ghorpade, D. Niemann, R. L. Cotter, M. R. Thylin, L. Epstein, J. M. Swartz, R. B. Shepard, X. Liu, A. Nukuna, and H. E. Gendelman. 1999. Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 73:8256-8267.